ROR1 contributes to melanoma cell growth and migration by regulating N-cadherin expression via the PI3K/Akt pathway.

作者: Natalia Brenda Fernández , Daniela Lorenzo , María Elisa Picco , Gastón Barbero , Leonardo Sebastián Dergan-Dylon

DOI: 10.1002/MC.22426

关键词:

摘要: The Receptor tyrosine kinase-like Orphan 1 (ROR1) is primarily expressed by neural crest cells during embryogenesis. Following a complete downregulation after birth, ROR1 was shown to re-express in various types of cancers. Little known about expression and function melanoma. Here we show that aberrantly both melanoma cell lines tumors its associates with poor Post-Recurrence Survival Using gain- loss-of-function approaches found enhances anchorage-dependent -independent growth cells. In addition, decreases adhesion increases motility migration. Mechanistically, induce upregulation Akt the mesenquimal markers N-cadherin vimentin. regulation relies on dependent independent mechanisms. does not affect Wnt canonical pathway but be engaged positive feedback loop Wnt5a. summary, contributes progression candidate biomarker prognosis. Although further studies are needed confirm this possibility, present work indicates good prospective target for cancer therapy. © 2015 Wiley Periodicals, Inc.

参考文章(47)
Daniel S. Widmer, Phil F. Cheng, Ossia M. Eichhoff, Benedetta C. Belloni, Marie C. Zipser, Natalie C. Schlegel, Delphine Javelaud, Alain Mauviel, Reinhard Dummer, Keith S. Hoek, Systematic classification of melanoma cells by phenotype-specific gene expression mapping. Pigment Cell & Melanoma Research. ,vol. 25, pp. 343- 353 ,(2012) , 10.1111/J.1755-148X.2012.00986.X
P Masiakowski, R.D. Carroll, A novel family of cell surface receptors with tyrosine kinase-like domain. Journal of Biological Chemistry. ,vol. 267, pp. 26181- 26190 ,(1992) , 10.1016/S0021-9258(18)35733-8
Carolina Berger, Daniel Sommermeyer, Michael Hudecek, Michael Berger, Ashwini Balakrishnan, Paulina J. Paszkiewicz, Paula L. Kosasih, Christoph Rader, Stanley R. Riddell, Safety of Targeting ROR1 in Primates with Chimeric Antigen Receptor–Modified T Cells Cancer immunology research. ,vol. 3, pp. 206- 216 ,(2015) , 10.1158/2326-6066.CIR-14-0163
Julie Caramel, Eftychios Papadogeorgakis, Louise Hill, Gareth J. Browne, Geoffrey Richard, Anne Wierinckx, Gerald Saldanha, Joy Osborne, Peter Hutchinson, Gina Tse, Joël Lachuer, Alain Puisieux, J. Howard Pringle, Stéphane Ansieau, Eugene Tulchinsky, A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma. Cancer Cell. ,vol. 24, pp. 466- 480 ,(2013) , 10.1016/J.CCR.2013.08.018
Suping Zhang, Liguang Chen, Bing Cui, Han-Yu Chuang, Jianqiang Yu, Jessica Wang-Rodriguez, Li Tang, George Chen, Grzegorz W. Basak, Thomas J. Kipps, ROR1 Is Expressed in Human Breast Cancer and Associated with Enhanced Tumor-Cell Growth PLoS ONE. ,vol. 7, pp. e31127- ,(2012) , 10.1371/JOURNAL.PONE.0031127
Mohammad Hojjat-Farsangi, Fatemeh Ghaemimanesh, Amir Hossein Daneshmanesh, Ali-Ahmad Bayat, Jafar Mahmoudian, Mahmood Jeddi-Tehrani, Hodjatallah Rabbani, Hakan Mellstedt, Inhibition of the receptor tyrosine kinase ROR1 by anti-ROR1 monoclonal antibodies and siRNA induced apoptosis of melanoma cells. PLOS ONE. ,vol. 8, ,(2013) , 10.1371/JOURNAL.PONE.0061167
D. Bogunovic, D. W. O'Neill, I. Belitskaya-Levy, V. Vacic, Y.-L. Yu, S. Adams, F. Darvishian, R. Berman, R. Shapiro, A. C. Pavlick, S. Lonardi, J. Zavadil, I. Osman, N. Bhardwaj, Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival Proceedings of the National Academy of Sciences of the United States of America. ,vol. 106, pp. 20429- 20434 ,(2009) , 10.1073/PNAS.0905139106
Vincent T. Bicocca, Bill H. Chang, Behzad Kharabi Masouleh, Markus Muschen, Marc M. Loriaux, Brian J. Druker, Jeffrey W. Tyner, Crosstalk between ROR1 and the Pre-B Cell Receptor Promotes Survival of t(1;19) Acute Lymphoblastic Leukemia Cancer Cell. ,vol. 22, pp. 656- 667 ,(2012) , 10.1016/J.CCR.2012.08.027
Bing Cui, Suping Zhang, Liguang Chen, Jianqiang Yu, George F. Widhopf, Jessie-F. Fecteau, Laura Z. Rassenti, Thomas J. Kipps, Targeting ROR1 Inhibits Epithelial–Mesenchymal Transition and Metastasis Cancer Research. ,vol. 73, pp. 3649- 3660 ,(2013) , 10.1158/0008-5472.CAN-12-3832
Pablo López-Bergami, Hasem Habelhah, Anindita Bhoumik, Weizhou Zhang, Lu-Hai Wang, Ze’ev Ronai, Receptor for RACK1 Mediates Activation of JNK by Protein Kinase C Molecular Cell. ,vol. 19, pp. 309- 320 ,(2005) , 10.1016/J.MOLCEL.2005.06.025